These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 22392065)

  • 21. Telmisartan-induced inhibition of vascular cell proliferation beyond angiotensin receptor blockade and peroxisome proliferator-activated receptor-gamma activation.
    Yamamoto K; Ohishi M; Ho C; Kurtz TW; Rakugi H
    Hypertension; 2009 Dec; 54(6):1353-9. PubMed ID: 19822796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative effects of angiotensin II AT-1-type receptor antagonists in vitro on human platelet activation.
    Montón M; Jiménez A; Núñez A; López-Blaya A; Farré J; Gómez J; Zalba LR; Sánchez de Miguel L; Casado S; López-Farré A
    J Cardiovasc Pharmacol; 2000 Jun; 35(6):906-13. PubMed ID: 10836725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin II upregulates acyl-CoA:cholesterol acyltransferase-1 via the angiotensin II Type 1 receptor in human monocyte-macrophages.
    Kanome T; Watanabe T; Nishio K; Takahashi K; Hongo S; Miyazaki A
    Hypertens Res; 2008 Sep; 31(9):1801-10. PubMed ID: 18971559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Telmisartan exerts renoprotective actions via peroxisome proliferator-activated receptor-γ/hepatocyte growth factor pathway independent of angiotensin II type 1 receptor blockade.
    Kusunoki H; Taniyama Y; Azuma J; Iekushi K; Sanada F; Otsu R; Iwabayashi M; Okayama K; Rakugi H; Morishita R
    Hypertension; 2012 Feb; 59(2):308-16. PubMed ID: 22252391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Propofol up-regulates expression of ABCA1, ABCG1, and SR-B1 through the PPARγ/LXRα signaling pathway in THP-1 macrophage-derived foam cells.
    Ma X; Li SF; Qin ZS; Ye J; Zhao ZL; Fang HH; Yao ZW; Gu MN; Hu YW
    Cardiovasc Pathol; 2015; 24(4):230-5. PubMed ID: 25600616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcriptional repression of ATP-binding cassette transporter A1 gene in macrophages: a novel atherosclerotic effect of angiotensin II.
    Takata Y; Chu V; Collins AR; Lyon CJ; Wang W; Blaschke F; Bruemmer D; Caglayan E; Daley W; Higaki J; Fishbein MC; Tangirala RK; Law RE; Hsueh WA
    Circ Res; 2005 Oct; 97(9):e88-96. PubMed ID: 16224068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The effect of angiotensin II on phosphoinositide-3 kinase/Akt cascade in cultured fibroblasts derived from patients with hypertrophic scars].
    Liu HW; Cheng B; Wu HJ; Gu YF; Chen X; Chen ZG; Liu WZ
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2010 Jan; 26(1):57-60. PubMed ID: 20432929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of telmisartan, valsartan and candesartan on mycophenolate mofetil pharmacokinetics in Japanese renal transplant recipients.
    Miura M; Satoh S; Kagaya H; Saito M; Inoue T; Ohkubo T; Habuchi T; Suzuki T
    J Clin Pharm Ther; 2009 Dec; 34(6):683-92. PubMed ID: 20175802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin II-induced neural differentiation via angiotensin II type 2 (AT2) receptor-MMS2 cascade involving interaction between AT2 receptor-interacting protein and Src homology 2 domain-containing protein-tyrosine phosphatase 1.
    Li JM; Mogi M; Tsukuda K; Tomochika H; Iwanami J; Min LJ; Nahmias C; Iwai M; Horiuchi M
    Mol Endocrinol; 2007 Feb; 21(2):499-511. PubMed ID: 17068200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Valsartan ameliorates the constitutive adipokine expression pattern in mature adipocytes: a role for inverse agonism of the angiotensin II type 1 receptor in obesity.
    Hasan AU; Ohmori K; Hashimoto T; Kamitori K; Yamaguchi F; Ishihara Y; Ishihara N; Noma T; Tokuda M; Kohno M
    Hypertens Res; 2014 Jul; 37(7):621-8. PubMed ID: 24599011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of valsartan on angiotensin II-induced migration of human coronary artery smooth muscle cells.
    Kohno M; Ohmori K; Nozaki S; Mizushige K; Yasunari K; Kano H; Minami M; Yoshikawa J
    Hypertens Res; 2000 Nov; 23(6):677-81. PubMed ID: 11131281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin subtype-2 receptors inhibit renin biosynthesis and angiotensin II formation.
    Siragy HM; Xue C; Abadir P; Carey RM
    Hypertension; 2005 Jan; 45(1):133-7. PubMed ID: 15534073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of the cell membrane angiotensin AT2 receptors in human leiomyosarcoma cells induces differentiation and apoptosis by a PPARγ - dependent mechanism.
    LÜtzen U; Zhao Y; Lucht K; Zuhayra M; Hedderich J; Cascorbi I; Culman J
    Neoplasma; 2017; 64(3):395-405. PubMed ID: 28253719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pioglitazone enhances cholesterol efflux from macrophages by increasing ABCA1/ABCG1 expressions via PPARγ/LXRα pathway: findings from in vitro and ex vivo studies.
    Ozasa H; Ayaori M; Iizuka M; Terao Y; Uto-Kondo H; Yakushiji E; Takiguchi S; Nakaya K; Hisada T; Uehara Y; Ogura M; Sasaki M; Komatsu T; Horii S; Mochizuki S; Yoshimura M; Ikewaki K
    Atherosclerosis; 2011 Nov; 219(1):141-50. PubMed ID: 21862012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [On angiotensin II receptor distribution after myocardial infarction in dogs].
    Qu XF; Li JJ; Xi Y; Shen JX; Xiu CH; Yue L; Wang GZ; Huang YL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Apr; 37(4):358-62. PubMed ID: 19791474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebral ischemia induced inflammatory response and altered glutaminergic function mediated through brain AT
    Justin A; Divakar S; Ramanathan M
    Biomed Pharmacother; 2018 Jun; 102():947-958. PubMed ID: 29710550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin type 1 receptor antagonists induce human in-vitro adipogenesis through peroxisome proliferator-activated receptor-gamma activation.
    Janke J; Schupp M; Engeli S; Gorzelniak K; Boschmann M; Sauma L; Nystrom FH; Jordan J; Luft FC; Sharma AM
    J Hypertens; 2006 Sep; 24(9):1809-16. PubMed ID: 16915030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of facilitation of sympathetic neurotransmission and angiotensin II-induced pressor effects in the pithed rat: comparison between valsartan, candesartan, eprosartan and embusartan.
    Balt JC; Mathy MJ; Pfaffendorf M; van Zwieten PA
    J Hypertens; 2001 Dec; 19(12):2241-50. PubMed ID: 11725169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Internalization of constitutively active N111G MUTANT of AT1 receptor induced by angiotensin II-receptor antagonists candesartan, losartan, and telmisartan: comparison with valsartan.
    Bhuiyan MA; Hossain M; Nakamura T; Ozaki M; Nagatomo T
    J Pharmacol Sci; 2010; 112(4):459-62. PubMed ID: 20308802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition or deletion of angiotensin II type 1 receptor suppresses elastase-induced experimental abdominal aortic aneurysms.
    Xuan H; Xu B; Wang W; Tanaka H; Fujimura N; Miyata M; Michie SA; Dalman RL
    J Vasc Surg; 2018 Feb; 67(2):573-584.e2. PubMed ID: 28434702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.